TP53 and cancer: Recent studies have shown that various types of cancer cells benefit from the activation of the MAGE-A family and gain a survival advantage by inhibiting the p53 signalling pathway and suppressing p53-dependent apoptosis via ubiquitination and degradation of p53 protein19, 20, 21, 22, 23, 24, 39, 40.